Advertisement

Clinical Evaluation of Atypical Glandular Cells Detected on Cervical Cytological Examination in a Tertiary Hospital

  • Urvashi MiglaniEmail author
  • Poonam Laul
  • Neha Bansal
  • Neeta Bindal
  • Sanjeev Miglani
Original Article
  • 23 Downloads

Abstract

Introduction

Evaluation of cervical cytology by Papanicolaou smear has assumed great importance in diagnosis of premalignant lesions of the cervix. One of the entities encountered infrequently on cervical cytology is atypical cells of glandular origin.

Materials and Method

An observational prospective study was conducted in the Department of Obstetrics and Gynaecology in Deen Dayal Upadhyay hospital over a period of 2 years, from August 2014 to August 2016. All the OPD or indoor patients who had a report of AGC-NOS Pap smear were evaluated for their socio-demographic profile and presence of risk factors. They were managed as per ASCCP guidelines. Statistical analysis was done by Chi-square test.

Result

A total of 3479 pap smears were reviewed in 2-year time period; out of which 77 (2.2%) were AGC and 24 (0.7%) smears had AGC with ASCUS. AGC was reported most commonly in perimenopausal age group (40–50 years) and was much more common in multiparous women (94%). The incidence of high-grade disease was significantly higher in women with AGC with ASCUS (37.5%) as compared to women with AGC (20%). The occurrence of cervicitis in women with AGC alone was significantly higher than those with AGC along with ASCUS.

Conclusion

AGC-NOS may represent a myriad of benign and malignant lesions and warrants a complete evaluation. Complete treatment of causative benign lesions is warranted.

Keywords

Papanicolaou smear AGC-NOS Cervicitis 

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare that there is no conflict of interest.

References

  1. 1.
    Solomon D, Davey D, Kurman R. The 2001 Bethesda system. JAMA. 2002;287:2114–9.CrossRefGoogle Scholar
  2. 2.
    Ribeiro VC, Correia L, Aguilar S, Paula T, Borrego J. Clinical implication of atypical glandular cells; a five year experience of a single institution in Portugal. Gynecol Obstet. 2015;5:311.  https://doi.org/10.4172/2161-0932.1000311.CrossRefGoogle Scholar
  3. 3.
    Pradhan D, Li Z, Ocque R, Patadji S, Zhao C. Clinical significance of atypical glandular cells in Pap tests: an analysis of more than 3000 cases at a large academic women’s center. Cancer Cytopathol. 2016;124(8):589–95.  https://doi.org/10.1002/cncy.21724.CrossRefPubMedGoogle Scholar
  4. 4.
    Zhao C, Florea A, Onisko A, Austin RM. Histologic follow-up results in 662 patients with Pap test findings of atypical glandular cells: results from a large academic womens hospital laboratory employing sensitive screening methods. Gynecol Oncol. 2009;114(3):3839.CrossRefGoogle Scholar
  5. 5.
    Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin. 2012;62(3):147–72.CrossRefGoogle Scholar
  6. 6.
    Holanda Marques JP, Costa LB, Pinto APDS, de Lima AF, Duarte MEL, Barbosa APF, de Medeiros PL. Atypical glandular cells and cervical cancer: systematic review. Rev Assoc Med Bras. 2011;57(2):229–33.CrossRefGoogle Scholar
  7. 7.
    Adhya AK, Mahesha V, Srinivasan R, Nijhawan R, Rajwanshi A, Suri V, Dhaliwal LK. Atypical glandular cells in cervical smears: histological correlation and a suggested plan of management based on age of the patient in a low-resource setting. Cytopathology. 2009;20(6):375–9.CrossRefGoogle Scholar
  8. 8.
    Asciutto KC, Henic E, Forslund O, Bjelkenkrantz K, Borgfeldt C. Age influences the clinical significance of atypical glandular cells on cytology. Anticancer Res. 2015;35(2):913–9.PubMedGoogle Scholar
  9. 9.
    Ludwin A, Ludwin I, Pityński K, Jach R, Banaś T, Stangel-Wojcikiewicz K, Horbaczewska A, Pietrus M. Prevalence of HPV-DNA in Pap smears containing ASC and AGC performed within population programme of prophylaxis and early detection of early cervical cancer. Przegl Lek. 2012;69(11):1189–93.PubMedGoogle Scholar
  10. 10.
    Naidu MSK, Suryakar AN, Swami SC, Katkam RV, Kumbar KM. Oxidative stress and antioxidant status in cervical cancer patients. Indian J Clin Biochem. 2007;22(2):140–4.  https://doi.org/10.1007/bf02913333.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Jiangrong W, Bengt A, Karin S, Peter S, Alexander P, Miriam E, et al. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study. BMJ. 2016;352:i276.Google Scholar

Copyright information

© Association of Gynecologic Oncologists of India 2019

Authors and Affiliations

  • Urvashi Miglani
    • 1
    Email author
  • Poonam Laul
    • 1
  • Neha Bansal
    • 1
  • Neeta Bindal
    • 1
  • Sanjeev Miglani
    • 2
  1. 1.Department of Obstetrics and GynaecologyDeen Dayal Upadhyay HospitalNew DelhiIndia
  2. 2.Sir Gangaram HospitalNew DelhiIndia

Personalised recommendations